A randomised, open label phase III trial with nimotuzumab, an anti-epidermal growth factor receptor monoclonal antibody in the treatment of newly diagnosed adult glioblastoma

DSpace Repository

A randomised, open label phase III trial with nimotuzumab, an anti-epidermal growth factor receptor monoclonal antibody in the treatment of newly diagnosed adult glioblastoma

Author: Westphal, Manfred; Heese, Oliver; Steinbach, Joachim P.; Schnell, Oliver; Schackert, Gabriele; Mehdorn, Maximilian; Schulz, Dirk; Simon, Matthias; Schlegel, Uwe; Senft, Christian; Geletneky, Karsten; Braun, Christian; Hartung, Joachim G.; Reuter, Dirk; Metz, Monika Warmuth; Bach, Ferdinand; Pietsch, Torsten
Tübinger Autor(en):
Braun, Christian
Published in: European Journal of Cancer (2015), Bd. 51, H. 4, S. 522-532
Verlagsangabe: Elsevier Sci Ltd
Language: English
Full text: http://dx.doi.org/10.1016/j.ejca.2014.12.019
ISSN: 0959-8049
DDC Classifikation: 610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)